Clinical trial Recruiting at 2 sites Interventional Ages 18 to 50 Women only

Digital fetal scalp stimulation during labor to identify fetal hypoxia

Official title: Evaluation of Fetal Response to Intrapartum Digital Fetal Scalp Stimulation Upon Detection of Suspected Loss of Fetal Well-being in Suspicious and Pathologic Cardiotocographic Recordings, to Identify Intrapartum Fetal Hypoxia.

Run by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · NCT07035028 · Data updated 2026-11-12

This trial will see if a brief digital stimulation of the fetal scalp during labor can improve heart-rate tracings and scalp blood results for babies with suspicious or pathological cardiotocography.

More Fetal Hypoxia trials

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexWomen only
Enrollment182 (estimated)
SponsorInstituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Academic / other
Locations2 sites (Madrid and 1 other locations)
StatusRecruiting
StartedJanuary 1, 2024
Main results expectedDecember 2025
Study endsDecember 2025
Registry record updatedJune 24, 2025
Trial IDNCT07035028 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Term (≥37 weeks), singleton, cephalic pregnancies with suspicious or pathological CTG patterns and eligibility for scalp evaluation are the intended participants.

Probably not a fit

This approach will not be appropriate for patients under 18, those with contraindications to scalp procedures, maternal HIV/hepatitis, or fetuses at increased risk of hemorrhage.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

When cardiotocography (CTG) shows a suspicious or pathological fetal heart-rate pattern during labor, clinicians perform a brief digital fetal scalp stimulation (dFSS) during a vaginal exam and record the immediate CTG response. Investigators compare those CTG responses with the reference fetal scalp blood (FBS) result, which measures fetal blood gases and pH. The dFSS intervention is short and non-invasive and is tested alongside standard care, with FBS performed as the gold-standard comparator when indicated. The study enrolls term, singleton, cephalic pregnancies at participating Madrid hospitals and tracks whether dFSS leads to improved CTG patterns and normal FBS values.

Why it matters

Potential benefit: If successful, dFSS could reduce the need for invasive fetal scalp blood sampling and speed decision-making about interventions during labor.

How similar studies have gone: Previous smaller studies and clinical reports have shown that scalp stimulation can produce fetal heart-rate accelerations, but large direct comparisons with fetal scalp blood sampling are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

Women with singleton pregnancy.

Cephalic presentation.

Gestational age greater than or equal to 37 weeks.

Pathological cardiotocographic record according to the criteria published by FIGO and with indication to perform a second-line complementary test, in our case a gold standard test of fetal scalp blood FBS, which confirms or not if there is a risk of loss of fetal well-being and the need for fetal extraction.

Signature of HIP and CI for data collection.

Exclusion criteria:

Under 18 years of age.

Contraindication for FBS

Uterine dilatation that does not make FBS possible.

HIV

Hepatitis

Fetuses at increased risk of hemorrhage.

Where it's running

  • Fundación Jimenez Diaz Y Hospital La Zarzuela
    Madrid, Spain
    Recruiting
  • Hospital Universitario Sanitas La Zarzuela
    Madrid, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.